There have been many different methods that have been used to occlude the vas deferens during vasectomy to try to make it as effective as a permanent sterilization as possible. Although there is no form of contraception that is exactly 100% for everyone forever, vasectomy …
Dr. Kavoussi presents result on targeted microsurgical denervation of spermatic cord for testicular pain at AUA meeting
Dr. Parviz Kavoussi presents his research validating a targeted microsurgical technique for spermatic cord denervation. Testicular pain is a common complaint that affects many men in the United States. When anatomic or pathologic processes cannot be identified, such as infection, masses, or other anatomic sources …
Dr. Kavoussi presents research on factors impacting couple’s decision making between vasectomy reversal and sperm retrieval/IVF in San Francisco at the AUA meeting.
There were over 16,000 urologists attending from all over the world at the 2018 American Urological Association national meeting in San Francisco. Dr. Parviz Kavoussi presented his research on the factors that impact a couple’s decision making when the male partner has had a vasectomy …
Dr. Kavoussi writes commentary in Hinman’s Atlas of Urologic Surgery textbook
As a regarded expert in the field of testicular pain, Dr. Kavoussi was selected to write a chapter in the Hinman’s Atlas of Urologic Surgery textbook. This text is a widely used book outlining procedures in urologic surgery utilized by urologists and resident and fellows …
Dr. Kavoussi publishes study on factors impacting couples’ decision making between vasectomy reversal and sperm retrieval/IVF.
Five-hundred thousand men in the United States undergo vasectomy annually. Approximately 6% of these men will change their minds about their choice of having undergone surgical contraception. The two options facing couples who want to conceive when the male partner has previously undergone vasectomy are …
Dr. Kavoussi serves on the executive advisory board of RAMSES advancing the use of robot assisted microsurgery.
Dr. Kavoussi has been a leading advocate for the use of robotics in the assistance with microsurgery, such as with vasectomy reversals. He states, “adding the precision of a machine to the skill and knowledge of anatomy and tissue handling for microsurgery has significantly advanced …
Toxic impact of Promescent on sperm published in Urology Gold Journal
Dr. Kavoussi and his laboratory team found that a commonly used topical medication for premature ejaculation, Promescent, is toxic for sperm. For men who undergo vasectomy reversal, surgical success is the first step. The couple then needs to optimize their odds of success at conception …
Kavoussi Family Outstanding Teacher Award given to Dr. Marc Goldstein
At the annual American Society for Reproductive Medicine annual scientific meeting and expo, the Kavoussi Family Outstanding Teacher Award is given to a teacher in reproductive medicine. The teacher who is awarded this scholarship is recognized as an outstanding educator in reproductive medicine. The award …
Dr. Parviz Kavoussi’s research on drug therapy and semen parameters presented at ASRM
Men who undergo vasectomy reversal and have low testosterone should not be treated with testosterone replacement, as it will suppress sperm production. There is no clear answer in the scientific research on whether Clomiphene Citrate, a commonly used medication to treat low testosterone in men …
The team at AFRM/Westlake IVF presents research on Promescent®’s impact on sperm at American Society for Reproduction Medicine Meeting
Approximately 20-30% of men complain of premature ejaculation, making it one of the most common sexual complaints in men. Promescent®, is a commonly used over the counter desensitizing spray used for the treatment of premature ejaculation. We sought to learn whether this treatment may have …